menu
    • menu

    Company profile for Aimed Bio

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AimedBio, founded in 2018 as a spin-off from Samsung Medical Center, is a preclinical-stage biotechnology company driving innovation in antibody-drug conjugates (ADCs) and bispecific antibodies. With its proprietary patient-derived, cell-based antibody discovery platform and translational research expertise, AimedBio develops targeted cancer therapies that maximize efficacy and minimize side effects. By combining the precision...
    AimedBio, founded in 2018 as a spin-off from Samsung Medical Center, is a preclinical-stage biotechnology company driving innovation in antibody-drug conjugates (ADCs) and bispecific antibodies. With its proprietary patient-derived, cell-based antibody discovery platform and translational research expertise, AimedBio develops targeted cancer therapies that maximize efficacy and minimize side effects. By combining the precision of antibodies with the potency of chemotherapy, AimedBio’s ADCs represent a breakthrough in safer, more effective cancer treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aimed Biokorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    10F, 11F MK TOWER, 67 JEONGUI-RO, SONGPA-GU, SEOUL
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aimedbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Boehringer Ingelheim Boosts Cancer ADC Portfolio With Aimedbio
    Boehringer Ingelheim Boosts Cancer ADC Portfolio With Aimedbio

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3167043/0/en/Boehringer-Ingelheim-advances-cancer-antibody-drug-conjugate-portfolio-with-asset-from-AimedBio.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share
    Samsung Biologics Enters Research Collaboration with AimedBio
    Samsung Biologics Enters Research Collaboration with AimedBio

    13 Sep 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-09-13/samsung-biologics-enters-research-collaboration-wi/?widget=listSection

    CONTRACT PHARMA
    13 Sep 2023
    Share Share
    GeneQuantum and AIMEDBIO Collaborate on First-in-Class ADC
    GeneQuantum and AIMEDBIO Collaborate on First-in-Class ADC

    18 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/genequantum-and-aimedbio-collaborate-on-a-first-in-class-antibody--drug-conjugate-301526935.html

    PRNEWSWIRE
    18 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search